Continuing Medical Education Conferences in Switzerland
Sep 25 - 27, 2019 | Free | Neurology
4th Congress of Swiss Federation of Clinical Neuro-Societies (SFCNS) is organized by IMK Institute for Medicine and Communication Ltd. and will be held during Sep 25 - 27, 2019 at Congress Center Basel, Basel, Basel-Stadt, Switzerland. The target audience for this medical event is Neurologists. Additional details will be posted as soon as they are available.
New Generation Neuroendoscopy Clinical Observer Course is organized by ENDOMIN College and will be held from Sep 25 - 27, 2019 at Endomin - Center for Endoscopic and Minimally Invasive Neurosurgery - Klinik Hirslanden, Zurich, Switzerland. Description: The two course directors, Professor Nikolai Hopf and Professor Robert Reisch have been pupils of Professor Axel Perneczky, pioneer of endoscopic and minimal invasive neurosurgery, and have been using endoscopic techniques since their very beginning of neurosurgical training. They have conducted 29 international courses only within the last seven years, teaching more than 500 international participants. They understand very well that integration of minimally invasive concepts into the daily surgical routine is not simple and requires a strong and stable strategy. Therefore, in this course you will: • hear conceptual lectures on modern endoscopic & minimally invasive neurosurgery • learn practical hints to set up and perform complex procedures • see how to avoid and handle complications • experience extensive case discussions • enjoy complex endoscopic procedures in the OR • discuss every operating step with the surgeon on-site Highlights: • didactic experience with more than 500 international trainees • small group (max. 8 neurosurgeons) guaranteeing intensive education • extensive discussion of complex cases • possibility to discuss your own cases with us • close-up observation of various complex live-surgeries Additional details will be posted as soon as they are available.
Amputation Prevention Symposium (AMP) Europe is organized by Education Event Impact GmbH & Co KG, Healthcare Made Practical (HMP) Communications LLC and will be held from Oct 02 - 04, 2019 at Congress Palace, Lugano, Ticino, Switzerland. Who Should Attend? • Interventional Cardiologists • Interventional Radiologists • Nurses, Technologists, and Other Allied Professionals • General Surgeons • Vascular Medicine Specialists • Podiatrists • Wound Care Specialists • Vascular Surgeons • Any Others Involved in the Treatment and Management of CLI Accreditation: The AMP Europe 2019, Lugano, Switzerland, 02/10/2019-04/10/2019 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 17 European CME credits (ECMEC®s). Description: Join us for the inaugural offering of the Amputation Prevention Symposium (AMP) in Europe. For more than 8 years, driven by a team of renowned multidisciplinary course directors, and led by Jihad A. Mustapha, MD, a pioneer in the field of interventional cardiology, AMP has served as an excellent forum to connect clinicians-interventional cardiologists and radiologists, vascular surgeons, and the entire limb salvage team-with the foremost experts in CLI to gain knowledge on the latest advances in revascularization and learn from one another to save limbs and save lives. The goal of AMP Europe is the same as Chicago: to save limbs and save lives. AMP Europe will deliver a practical program on CLI prevalence, diagnosis, treatment (surgical, endovascular, and medical management), and post-revascularization surveillance. The inaugural congress will be tailored to the specific needs of the healthcare systems throughout Europe and beyond, and renowned faculty will give participants the opportunity to gain insight and perspective on CLI advances from around the world. Learning Objectives: After attending AMP, participants should be able to: • Apply a comprehensive, multidisciplinary best practice approach for patients with advanced peripheral arterial disease (PAD) and critical limb ischemia (CLI) at risk for major amputation • Describe arterial angiosome anatomy in conjunction with cutaneous and ultrasonic angiosome mapping in patients with advanced tibio-pedal arterial disease at risk for major amputation • Describe the surgical approach to post-revascularization limb salvage for patients with CLI at risk for major amputation • Implement a diagnostic algorithm which includes selective angiography as a critical step for patients with CLI who are at risk for amputation • Incorporate advanced tibio-pedal access in combination with antegrade access in limb salvage procedures • Utilize digital branch access during CLI interventions • Implement transcollateral interventions in below-the-knee and below-the-ankle interventions • Describe tips and tricks for safe and effective surgical and endovascular treatment of CLI from access to closure • Describe unique considerations when evaluating the diabetic foot ulcer in the setting of CLI • Describe the current state of wound oriented revascularization in the patient with CLI • Describe the algorithm to identify and treat mixed arterial and venous wounds in the patient with CLI • Describe when to refer the patient with CLI and osteomyelitis for an ID consult • Describe when to urgently refer a patient with CLI and wounds to a wound care specialist • Describe when to urgently refer a patient post-revascularization back to the revascularization specialist • Describe current medical management of the patient with advanced PAD or CLI • Describe currently available drug-eluting technology for the treatment of above-the-knee and below-the-knee lesions in the patient with CLI • Describe current wire, catheter, balloon, crossing, atherectomy, re-entry, and closure devices available for treatment of CLI, and describe mechanism of action and when most appropriate to utilize • Describe the role of atherectomy in CLI and its application in amputation prevention Treat complex chronic total occlusions in tibial and pedal arterial vessels in the patient with CLI • Implement procedural and technological advances in wound care practices for patients facing major amputation due to advanced PAD, advanced non-healing wounds, and gangrene Additional details will be posted as soon as they are available.
Oct 02 - 03, 2019 | EUR €999 | Pharmacy and Medicine
D4 Europe - Data-Driven Drug Development is organized by Front Line Genomics and will be held from Oct 02 - 03, 2019 at Hyperion Hotel Basel, Basel, Basel-Stadt, Switzerland. Description: D4 Europe is ram packed full of case studies – opportunities to get into the weeds, learn and be inspired. Broken down into two sections (‘Enabling Science’ and ‘Doing Science’), every session has been carefully screened to ensure that data and evidence is presented to back up the incredible work that’s being pioneered within pharma companies. This is a deep-learning environment. The format is simple. 100 senior technical and scientific leaders in the same room. This is designed to ensure that you leave the event not just armed with new knowledge, but with a renewed list of contacts who you’ve actually had the time to spend time getting to know. Don’t commit to a 1000 person meeting where you learn nothing and get face-time with no-one for longer than two minutes. D4 Europe is a harbour from the storm, where you can spend two highly; productive days in a friendly, welcoming environment where you will meet the right people and develop the right relationships to move your biodata capabilities forward. Key Benefits of Attending: • Learn and get inspired from listening to 20 case studies presenting data, evidence, lessons learned, mistakes and insights that will drive your own biodata capabilities forward • Understand and leverage the fast emerging role of the healthcare data ecosystem in transforming drug discovery and development • Build your biodata capabilities from the bottom up, from both a technical and scientific standpoint. • Get straight past the hype and vision and into the detail on AI/ML as a tool to build, manage and examine knowledge and vast data sets • Spend quality time with other senior level practitioners from Europe’s leading pharma organizations, and leave armed with not just new ideas, but a new support network This is the most impressive pharma-focused speaker line-up ever assembled for an event on this topic, on a diverse array of subjects tackling THE critical problems in drug development. D4 Features Data/Evidence Driven Case Studies in the Following Areas: Getting the Most Out of Biodata • Biodata integration • Data landscaping • FAIR, achieving ROI and making the business-case for investment • Harnessing complex data sets • Applying AI/ML/ANN approaches • Automated knowledge management and building/leveraging knowledge graphs • Transforming data into knowledge • How to build a biopharma company from scratch in a new data-driven era The Healthcare Data Ecosystem • Leveraging healthcare data from the many siloes that exist • Planning for the growing role of the patient. • Predicting patient response using machine learning techniques • Market access and convincing payors • Driving new insights and treatments for cancer • Accelerating interoperability Target Discovery and Validation • Omics data-driven target discovery • Leveraging genetic-driven insights • The role of AI/ML in target ID Enhancing Drug Discovery and Development • How to ‘surf on the data lake’ • Data flows, FAIRness and integration in the context of drug discovery • Enhancing the progression from compounds into hits/leads • Using advanced analytics and AI • Re-thinking drug design via AI • Phenotypic approaches to accelerate discovery Filling Gaps in Translational Research • Drug repurposing • Method benchmarking • Human models • Interpretation of Real-World Data • Data-driven problem solving • Using Artificial Neural Networks to gain clinically actionable insights
Oct 04, 2019 | EUR €2200 | Plastic and Reconstructive Surgery
Microfat- Nanofat-PRP- Stroma Vascular Fraction (SVF) is organized by Forever Institut Academy and will be held on 04, 2019 at Forever Laser Institute Sa, Geneva, Switzerland. Description: Microfat / Nanofat grafting procedure is a new technology allowing a great improvement of the texture, elasticity and glow of the skin: a real rejuvenation. What will you learn? • To work on a regenerative procedure • To use appropriate devices • A new innovative procedure to offer your patients: improvement of the texture, elasticity and glowing of the skin with a lifting effect Educational methods: Live case observation, Hands-on, Video, Lectures, On-site • The discovery of ADSCs in adipose tissue leads to Microfat and nonfat technique • It’s an emulsified suspension with regenerative capacities • Injectable through fine needle or cannula • Procedure involved only mechanical force • SVF is main component • Easy to collect • Approved devices • 1 day treatment • Results of trials confirmed safety Advantages of the procedure: Who is this course for? Plastic surgeons, dermatologists, aesthetic doctors and ophthalmologists Clinical results: Microfat, Nanofat grafting can be effective in skin rejuvenation to increase vascularisation, neocollagenesis, nerve and tissue regeneration Results in hydration and stimulation of skin trophicity. Restoration of facial balance, refreshed look, optimize beauty, softening deep folds, smoothing wrinkles and fine lines, enhancing facial contours Healthy and fresh skin, a reflexion of inner health and vitality. It’s soft, moisturized with an even tone. Additional details will be posted as soon as they are available.
Oct 08, 2019 | Free | Biotechnology
Biomanufacturing Strategy Meeting Europe 2019 is organized by Proventa International and will be held on Oct 08, 2019 at Radisson Blu Hotel, Zurich Airport, Zurich, Switzerland. Course Description: By creating an interactive space where business leaders in the biomanufacturing industry can share ideas to hopefully solve shared challenges, Proventa International helps biotech and pharma companies build meaningful partnerships via our executive strategy meetings. Unlike typical biomanufacturing conferences, the Biomanufacturing Strategy Meeting gathers director-level executives only so you can be sure to meet primary decision makers from large and emerging organizations. Not like biomanufacturing summits, our unique format enables you to explore pressing industry topics like upstream/downstream, single-use technologies, QMS/PAT and more with experienced professionals. Our executive roundtable discussions let each delegate raise relevant questions and contribute valuable insights, something you would find almost impossible at a biomanufacturing conference. Another key feature that makes us different from biomanufacturing conferences is our pre-qualified one-to-one meetings. With our extensive network of biomanufacturing experts in Switzerland and around the world, you can count to meet someone who can help you strategize for your business goals. Need help with implementing continuous manufacturing? Let us know so we can schedule your one-to-one meeting with an expert. Business leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for: • Process Development & Engineering • Quality Sciences Compliance • Upstream Drug Substance Development • Analytical Technology • Cell Culture Manufacturing • Validation Manufacturing Science • Cell Line Engineering • Risk Management • Purification Development • Bioprocessing R&D Analytics • Preclinical Manufacturing • CMC • Technology and Standardisation • Early Stage Bioprocess Development • Quality Operations • Product Supply Additional details will be posted as soon as they are available.
Cell and Gene Therapy Strategy Meeting Europe 2019 is organized by Proventa International and will be held on Oct 09, 2019 at Radisson Blu Hotel, Zurich Airport, Zurich, Switzerland. Course Description: Creating an interactive environment where business leaders can share the latest innovation and discuss relevant industry challenges, Proventa International has been connecting large to emerging biotech and pharma companies worldwide. Our Cell & Gene Therapy Strategy Meeting is not your typical stem cell conference. Our delegates are mainly c-level executives so you can be sure you only engage in meaningful conversations with primary decision makers. Unlike cell therapy conferences, our unique format enables you to dive deep into industry topics like immunotherapies, precision medicine, drug safety and more. Interactive and spontaneous, our executive roundtable discussions let you raise questions relevant to your business and contribute research-based insights to help others. Our pre-qualified one-to-one meetings, another feature you can’t find in gene therapy summits, connect you with a subject matter expert in our network. Need strategies on global logistics? Hit us up so we can find a professional to help you strategize for your goals. Business leaders who will benefit from attending include Chief Executive Officer, Chief Scientific Officer, SVPs, EVPs, VPs, Executive Director, Director and Global Head responsible for: • Cell Therapy • Immune Deficiencies • Cell Engineering • CAR-T • Biotherapeutics • Cellular Immunotherapy • Regenerative Medicine • Supply Chain and Manufacturing Additional details will be posted as soon as they are available.
Festival of Biologics 2019 is organized by Terrapinn Holdings Ltd and will be held from Oct 15 - 17, 2019 at Congress Center Basel, Basel, Basel-Stadt, Switzerland. Description: The Festival of Biologics is Europe’s most important gathering of senior health and biologic professionals. With the combination of four incredible events - #FOB2019 is your opportunity to network with 1500+ attendees, hear from 350+ speakers, explore and be part of this year’s most important Biologics event. The Festival of Biologics brings together the pioneers doing the most innovative work within the industry and across the whole value chain, to share their unique insights with you. The event looks at commercializing and pushing forward the entire developmental pipeline as well as focusing on the hottest new individual therapeutics. With both a conference and exhibition, the show brings together industry leaders to meet, discuss and showcase their work in the biologics, biopharma and immunotherapy fields, just to name a few. The Congress hosts high-level speakers hailing from big pharma, biotech, academia, regulatory bodies, investor groups, and associations, discussing topics representing key challenges within their industries, new data, case studies, and research. This year, presentations will move through the entire development pipeline and focus on commercial applications. Join thousands of attendees across the three days to maximise your time with four conferences in one. Discover new innovations and build new business relations on our exhibition floor with solution providers, biotech industry leaders and world class pharma professionals. Find out about the latest developments in the industry with our Start Up Zone or Poster Display where leading and emerging professionals can exhibit their findings. Additional details will be posted as soon as information is available.
Oct 16 - 18, 2019 | Free | Infectious Disease
VED 2019 – Vaccines for Enteric Diseases is organized by Meetings Management and will be held from Oct 16 - 18, 2019 at Lausanne, Vaud, Switzerland. Additional details will be posted as soon as they are available.
Oct 16, 2019 | Free | Pharmacy and Medicine
Regulatory Affairs Strategy Meeting Europe 2019 is organized by Proventa International and will be held on Oct 16, 2019 at Radisson Blu Hotel, Zurich Airport, Zurich, Switzerland. Course Description: Designed to build meaningful partnerships among business leaders worldwide, Proventa International’s Regulatory Affairs Strategy Meeting is not like most pharmaceutical regulatory affairs conferences. With all the delegates pre-qualified, you can be sure that you only meet and engage with primary decision makers of top and emerging biotech, pharma, IT and academic organizations. While regulatory affairs conferences expose you to huge pools of industry professionals with varied levels of experience and seniority, our Regulatory Affairs Strategy Meeting aims to provide insightful conversations with director-level executives. Another feature you can’t find in regulatory affairs events is our executive roundtable discussions. Personalized for each delegate, these discussions allow of in-depth exchanges on pharmaceutical regulation updates, industry trends and strategic challenges. These 60-minute sessions also give way for anyone who wants to raise their questions or share their expertise. Our Regulatory Affairs Strategy Meeting also lets you meet expert/s to help you strategize for short and long-term goals via our pre-scheduled one-to-one meetings. Depending on your strategic priorities, we connect you with the right professional from our vast network of pharmaceutical regulation experts in Boston and around the globe. Need help with CMC or Regulatory Operations? Contact us today so we can connect you with a subject matter expert! Business leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for: • Chemical Candidate Selection • Data Package Completeness • Risk Assessments • Regulatory agency interaction • Premarket approvals Labeling • Advertising • Clinical Evaluation • Postmarket Surveillance • Orphan Drug Submissions • Facility Inspections • Pricing and Market Authorisation Approval • Product Life Cycle Management • Quality review • Clinical trial applications • Marketing applications • Compliance Change Control Additional details will be posted as soon as they are available.